SRPT 8-K 2026-09-23
Sarepta Therapeutics, Inc. (SRPT) 8-K dated 2026-09-23 — accession 0001193125-26-399416.
Sarepta Therapeutics, Inc. (SRPT) is a biotechnology company listed on US.
Sarepta Therapeutics, Inc. filed a 8-K on 2026-09-23. Accession 0001193125-26-399416.
This 8-K covers: Material agreement (Item 1.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported SRPT revenue for 2025-12-31 was $2.20B. Net income was -$713.4M. Revenue was up 15.6% from 2024-12-31 to 2025-12-31. SRPT currently screens at market cap $2.34B.
Not investment advice. The SRPT SEC hub lists recent forms. The stock page is the research view.